Profile of blinatumomab and its potential in the treatment of relapsed/refractory acute lymphoblastic leukemia

Josep Maria Ribera, Albert Ferrer, Jordi Ribera, Eulàlia Genescà

Research output: Contribution to journalArticleResearchpeer-review

Fingerprint

Dive into the research topics of 'Profile of blinatumomab and its potential in the treatment of relapsed/refractory acute lymphoblastic leukemia'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology